Tinea Pedis
📧 Sign up to get email alerts when something new happens for Tinea Pedis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-01-06FDA Approved: NAFTIFINE HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical's Naftifine hydrochloride under an Original Application; it is a topical antifungal indicated for tinea corp…
-
FDA approval · 2015-12-18FDA Approved: LOTRIMIN ULTRA ATHLETES FOOT — Supplemental Application (Bayer Healthcare LLC.)
FDA approves Bayer's supplemental application for LOTRIMIN ULTRA ATHLETES FOOT containing butenafine hydrochloride, expanding the labeling t…
-
FDA approval · 2015-10-30FDA Approved: CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE — Original Application (Glenmark Pharmaceuticals Inc. USA)
FDA approved Glenmark's generic topical combination of clotrimazole and betamethasone dipropionate (ANDA 202894). It is indicated for inflam…
-
FDA approval · 2015-10-14FDA Approved: CICLOPIROX — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for Ciclopirox from Padagis Israel Pharmaceuticals Ltd, indicating an update to the product's labeli…
-
FDA approval · 2015-10-08FDA Approved: CICLOPIROX — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Ciclopirox from Sun Pharmaceutical Industries, Inc., under the ANDA framework. The approval indi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-09-11FDA Approved: CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE — Supplemental Application (E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC)
FDA approves a supplemental application for clotrimazole and betamethasone dipropionate (topical antifungal with corticosteroid) from E. Fou…
-
CLINICAL_TRIALS trial_result · 2015-09-10Clinical Trial Update: Prevalence and Clinical Characteristics of the Fungal Nail and Feet Infection in Patients With Hallux Valgus
This clinical trial update describes the prevalence and clinical characteristics of fungal nail infections and other foot infections in pati…
-
FDA approval · 2015-08-25FDA Approved: TERBINAFINE — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for terbinafine hydrochloride (NorthStar Rx LLC). This action updates labeling/indications for the p…
-
FDA approval · 2015-08-19FDA Approved: OXISTAT — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for Oxistat (oxiconazole nitrate) from ANI Pharmaceuticals, Inc.
-
FDA approval · 2015-07-15FDA Approved: ECONAZOLE NITRATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for econazole nitrate from Sun Pharmaceutical Industries, Inc., resulting in an approved update rela…
-
FDA approval · 2015-03-03FDA Approved: OXISTAT — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for OXISTAT (oxiconazole nitrate) submitted by ANI Pharmaceuticals. The update modifies the labe…
-
CLINICAL_TRIALS trial_result · 2015-01-27Clinical Trial Update: Comparative Safety and Efficacy Study of New Bifonazol Spray vs Terbinafine Solution vs Placebo [Phase 2]
Phase 2 trial comparing a new bifonazole spray with terbinafine topical solution and placebo for treating tinea pedis, with study status com…
-
FDA label_change · 2015-01-26FDA Approved: OXISTAT — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for OXISTAT (oxiconazole nitrate) submitted by ANI Pharmaceuticals, Inc.
-
FDA approval · 2015-01-05FDA Approved: CLOTRIMAZOLE — Supplemental Application (Rite Aid Corporation)
FDA approved a supplemental application for clotrimazole submitted by Rite Aid Corporation, indicating an updated/expanded approval for this…
-
FDA approval · 2014-12-01FDA Approved: CICLOPIROX — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for Ciclopirox from Glenmark Pharmaceuticals Inc., USA.
-
FDA approval · 2014-11-24FDA Approved: LAMISIL AT CREAM — Supplemental Application (Voyant Beauty Inc.)
The FDA approved a supplemental application for LAMISIL AT CREAM (terbinafine hydrochloride) by Voyant Beauty Inc., indicating regulatory cl…
-
FDA approval · 2014-10-10FDA Approved: NAFTIN — Supplemental Application (Legacy Pharma USA Inc.)
FDA approved a supplemental application for NAFTIN (naftifine hydrochloride) from Legacy Pharma USA Inc.
-
FDA approval · 2014-09-24FDA Approved: NAFTIN — Supplemental Application (Legacy Pharma USA Inc.)
FDA approves a supplemental application for Naftin (naftifine hydrochloride) by Legacy Pharma USA Inc., resulting in labeling updates throug…
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Evaluation of Preclinical Toxicity andTherapeutic Efficacy of Kandhaga Rasayanam in Padarthamarai [Phase 2]
This clinical trial update reports the completion of Phase 2 evaluation of Kandhaga Rasayanam in Padarthamarai for various tinea infections,…
-
CLINICAL_TRIALS trial_result · 2014-05-06Clinical Trial Update: Clinical Equivalence of Two Generic Butenafine Hydrochloride 1% Creams as Compared to Lotrimin Ultra Cream in Patients With Interdigital Tinea Pedis [Phase 1]
Phase 1 trial evaluating clinical equivalence of two generic butenafine hydrochloride 1% creams compared with Lotrimin Ultra Cream for inter…
-
CLINICAL_TRIALS trial_result · 2014-05-06Clinical Trial Update: Evaluate the Clinical Equivalence of Two Naftifine HCl 1% Creams in Patients With Interdigital Tinea Pedis [Phase 1]
Phase 1 trial update evaluating whether two Naftifine HCl 1% Cream formulations are clinically equivalent in patients with interdigital tine…
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: A Therapeutic Equivalence Study of Two Oxiconazole Nitrate Topical Cream Treatments for Patients With Tinea Pedis [Phase 1]
A Phase 1 clinical trial comparing two oxiconazole nitrate topical cream formulations for tinea pedis to evaluate therapeutic equivalence.
-
CLINICAL_TRIALS trial_result · 2013-12-27Clinical Trial Update: Efficacy and Safety of Terbinafine Film Forming Solution in Patients With Tinea Pedis [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of terbinafine film-forming solution for tinea pedis has completed, with results p…
-
FDA approval · 2013-11-14FDA Approved: LUZU — Original Application (Bausch Health US, LLC)
FDA approved LUZU (luliconazole) as a topical antifungal for the treatment of superficial fungal infections of the skin caused by dermatophy…
-
FDA approval · 2013-11-13FDA Approved: LAMISIL AT — Supplemental Application (Karo Healthcare Inc.)
The FDA approved a supplemental application for LAMISIL AT (terbinafine hydrochloride) submitted by Karo Healthcare Inc.